ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

House, Senate Must Resolve Major Differences In Authorization Bills

September 12, 1980

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

Lasker Awards Announced

September 25, 2009

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

FTC Cigarette Test Should Be Broadened, Cancer Panel Finds

December 16, 1994

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993